Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

about

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

P2860

Q36700993-8660A95B-6AE4-41B7-B424-C80C845C63B0

P2860

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

Item

http://www.wikidata.org/entity/Q35866976

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

@ast

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

@en

type

Item

label

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

@ast

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

@en

prefLabel

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

@ast

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

@en

P1476

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

@en

P2093

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Lynda A Morrison

http://www.w3.org/2001/XMLSchema#string

Maria Korom

http://www.w3.org/2001/XMLSchema#string

Michelle C Mitchell

http://www.w3.org/2001/XMLSchema#string

Tamara P Blevins

http://www.w3.org/2001/XMLSchema#string

Yinyi Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A new mathematical model for relative quantification in real-time RT-PCR

Serum antibodies to herpes simplex virus type 1 during active oral herpes infection

Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans

Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.

Evidence for differences in immunologic and pathogenesis properties of herpes simplex virus 2 strains from the United States and South Africa.

Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

Efficacy results of a trial of a herpes simplex vaccine.

P304

e0144738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0144738

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert B Belshe

P577

2015-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286989002

http://www.w3.org/2001/XMLSchema#string

P698

26658766

http://www.w3.org/2001/XMLSchema#string

P932

4682838

http://www.w3.org/2001/XMLSchema#string

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

about

P2860

P2860

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932